William Blair Downgrades Terns Pharmaceuticals (TERN) to Market Perform

April 7, 2026 12:20 PM

William Blair analyst Andy Hsieh downgraded Terns Pharmaceuticals (NASDAQ: TERN) from Outperform to Market Perform.The analyst comments "We are downgrading ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found